KPRX (Kiora Pharmaceuticals) Common Stock: $0.28 Mil (As of Mar. 2026)


KPRX Kiora Pharmaceuticals Inc KPRX
32 GF Score
Price $2.65
! 3 Warning Signs
View Full Analysis

What is Kiora Pharmaceuticals Common Stock?

Kiora Pharmaceuticals KPRX +1.74% 32 Common Stock is $0.28 Mil as of Mar. 2026. GuruFocus rates KPRX with a GF Score™ of 32/100. The stock has 3 warning signs investors should review.

Kiora Pharmaceuticals's quarterly common stock increased from Sep. 2025 ($0.27 Mil) to Dec. 2025 ($0.28 Mil) and increased from Dec. 2025 ($0.28 Mil) to Mar. 2026 ($0.28 Mil).

Kiora Pharmaceuticals's annual common stock increased from Dec. 2023 ($0.08 Mil) to Dec. 2024 ($0.27 Mil) and increased from Dec. 2024 ($0.27 Mil) to Dec. 2025 ($0.28 Mil).

Kiora Pharmaceuticals Common Stock Historical Data

* Premium members only.

The historical data trend for Kiora Pharmaceuticals's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Kiora Pharmaceuticals Common Stock Chart

Kiora Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.02 0.08 0.27 0.28

Kiora Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 0.27 0.27 0.28 0.28
KPRX
32GF Score
Kiora Pharmaceuticals Inc KPRX
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Kiora Pharmaceuticals Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of $0.28 Mil mean?
Kiora Pharmaceuticals (KPRX) has a Common Stock of $0.28 Mil as of Mar. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kiora Pharmaceuticals and its competitors.
Is Kiora Pharmaceuticals' Common Stock too high?
Kiora Pharmaceuticals' current Common Stock is $0.28 Mil. Overall, Kiora Pharmaceuticals has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Kiora Pharmaceuticals' Common Stock compare to PHIO and PBM?
Kiora Pharmaceuticals' Common Stock of $0.28 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Biotechnology company?
A good Common Stock depends on the Biotechnology industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Kiora Pharmaceuticals and its competitors. Kiora Pharmaceuticals's current Common Stock is $0.28 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Kiora Pharmaceuticals stock overvalued right now?
Kiora Pharmaceuticals (KPRX) has a current Common Stock of $0.28 Mil. The current Common Stock is $0.28 Mil. Kiora Pharmaceuticals' overall GF Score™ is 32/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Kiora Pharmaceuticals (KPRX), the current Common Stock is $0.28 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Kiora Pharmaceuticals Business Description

Address 169 Saxony Road, Suite 212, Encinitas, CA, USA, 92024
Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.
32GF Score

Get the complete analysis for KPRX

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.65
Price